The Raymond James Med Tech team, located in both the U.S. and Europe, stays agile to serve companies developing innovative products and technologies for the diagnosis, monitoring and treatment of medical conditions. Our team is led by four senior bankers who have long-standing relationships with key industry executives and broad transaction experience, including substantial cross-border deal execution. Their expertise helps clients focus on providing differentiated and cost-effective tools that improve clinical outcomes and increase the standard of care. The team is supported by three equity research analysts, covering more than 40 publicly traded medical device and diagnostic companies.
Transaction history may include a transaction completed by a Raymond James banker while at a former firm.